Femasys Inc. (FEMY) vs GlucoTrack, Inc. (GCTK)
Femasys Inc. and GlucoTrack, Inc. are both Medical Instruments & Supplies companies. Femasys Inc. is the larger, with a market value of $20.4M against $1.9M — 11.0× the size. Femasys Inc. grew revenue faster over the last twelve months: 21.9% against −60.6%. GlucoTrack, Inc. has the higher net margin (0.00% vs −534.3%) and the higher return on invested capital (0.00% vs −176.9%). Across the 17 metrics below, Femasys Inc. leads on 9 and GlucoTrack, Inc. on 8.
Valuation
Profitability
| Metric | FEMY | GCTK | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 60.95% | 0.00% | 54.62% |
| Operating margin | (763.90%) | 0.00% | 1.64% |
| Net margin | (534.27%) | 0.00% | 0.00% |
| Free cash flow margin | (786.02%) | 0.00% | 1.61% |
| Return on equity | (443.65%) | (620.63%) | 0.00% |
| Return on assets | (94.25%) | (272.48%) | 0.00% |
| Return on invested capital | (176.91%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack